Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] SK hynix (000660 / SKHY) – SK Securities | AI Memory · NAND Tiering · Earnings Re-rating / 2026-02-24 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q4 2023 Earnings Presentation / 2024-01-31 IR Room
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Supply Constraints · Memory Pricing · Earnings Growth / 2026-05-21 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | ADR Listing · HBM Pricing · Valuation Re-rating / 2026-06-30 Research
  • [Research] Samsung SDI (006400/KS) – SK Securities | Prominent Base Effects · Conservative CapEx Management · Compelling Valuation / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Commodity DRAM · ASP Resilience · Earnings Growth / 2026-07-29 Research
  • [Research] ABL Bio (298380) – Yuanta Securities | Givastomig Efficacy · Bispecific ADC · Platform Valuation / 2026-01-29 Research
  • [Research] LigaChem Biosciences (141080) – Eugene Investment & Securities | Pipeline Clinical Progression · Licensing Revenue · Earnings Turnaround / 2025-02-17 Research

[Research] Samsung SDI (006400) – Hanwha Investment & Securities | US ESS Surges · 4Q LFP Ramp-Up · Cyclical Bottom Passed / 2026-02-03

Posted on February 3, 2026August 22, 2026 By ksb220805@gmail.com

Brokerage : Hanwha Investment & Securities

Analyst : Yong-wook Lee, Ye-jin Go (RA)

Investment Rating : Buy (Maintained)

Target Price : KRW 430,000 (Raised)

Core Momentum : Passing an operational trough following 4Q25 earnings resilience, supported by rapid growth in US ESS shipments (+70–80% YoY) and 4Q26 North American LFP production maximizing AMPC credits toward a quarterly turnaround.

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: Buy (Maintained), Target Price KRW 430,000 (Raised)
  • Market Data (As of 2026-02-02): Current Price KRW 356,000 (Upside Potential 20.8%), Market Cap KRW 28.69 Trillion, Shares Outstanding 80,586 Thousand, Foreign Ownership 23.7%
  • Key Financial Forecasts (2025P → 2026E → 2027E):
    • Revenue: KRW 13.27 Trillion → KRW 15.48 Trillion → KRW 21.14 Trillion
    • Operating Profit: KRW -1.72 Trillion → KRW -577.0 Billion (Loss Narrowed) → KRW 1.60 Trillion (Turnaround)
    • EBITDA: KRW 401.0 Billion → KRW 1.82 Trillion → KRW 4.04 Trillion
    • Net Profit (Controlling): KRW -649.0 Billion → KRW -411.0 Billion (Loss Narrowed) → KRW 954.0 Billion (Turnaround)
    • EPS: KRW -8,427 → KRW -5,342 (Loss Narrowed) → KRW 12,333 (Turnaround)
    • ROE: -3.2% → -2.0% → 4.6%
    • PER / PBR: -28.1x / 0.9x → -66.6x / 1.4x → 28.9x / 1.4x
    • EV/EBITDA: 65.5x → 21.5x → 9.7x
    • Net Debt: KRW 9.78 Trillion → KRW 10.11 Trillion → KRW 10.08 Trillion

🚀 2. [Market Opportunities & Business Outlook]

  • 4Q25 Earnings Review & 1Q26 Outlook:
    • 4Q25 Review: Revenue reached KRW 3.9 Trillion and Operating Loss was KRW -292.2 Billion (Loss of KRW -379.0 Billion excluding AMPC), beating lowered market consensus. Client compensation and record ESS sales from the STLA JV ramp-up supported results.
    • 1Q26 Outlook: Projected Revenue of KRW 3.5 Trillion and Operating Loss of KRW -289.6 Billion (Loss of KRW -386.7 Billion excluding AMPC). Automotive battery revenue is forecast to drop 22% QoQ on compensation base effects, but ESS margins are expected to improve to OPM 4% (including AMPC) as one-off costs expire.
  • 2026 Turnaround Drivers & Medium-Term Catalysts:
    • Annual Volume Growth: Full-year shipments are forecast to expand +24% YoY, led by US ESS shipments projected to surge +70–80% YoY.
    • EV & Cylindrical Recovery: Ongoing demand recovery in European EV and power tool cylindrical cells, alongside entry expectations for Hyundai/Kia mass-market EV models.
    • 4Q26 Operating Inflection: Mass production of North American LFP lines starting in 4Q26 is set to maximize AMPC benefits, driving expectations for a quarterly operating profit turnaround. Financial stability is supported by disciplined CapEx and potential SDC stake utilization.

📝 Editor’s Comment (Perspective)

The analyst views Samsung SDI as a battery manufacturer moving past its cyclical trough with limited further downside, having absorbed the bulk of client churn and sector headwinds. This perspective emphasizes that surging US ESS shipment growth (+70–80% YoY) and the 4Q26 startup of North American LFP lines maximizing AMPC credits outweigh the temporary revenue dip caused by expired 1Q client compensation.

To evaluate the ongoing validity of this investment thesis, key monitoring factors include the quarterly execution of US ESS deliveries supporting the projected +24% YoY full-year shipment expansion, progress on battery supply programs for Hyundai/Kia mass-market EVs, and the timely commercial ramp-up of the North American LFP line in 4Q26. These operational milestones can be verified through upcoming quarterly earnings releases, official company IR presentations, and periodic statutory filings.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, EV & Battery

Post navigation

Previous Post: [Research] ABL Bio (298380) – Kiwoom Securities | ABL301 Deprioritization · ABL001 Valuation · Grabody B Validity / 2026-02-02
Next Post: [Research] Samsung SDI (006400) – DS Investment & Securities | ESS Revenue Surge · 4Q26 Turnaround · Physical AI Expansion with 46-Series & All-Solid-State / 2026-02-03

Related Posts

  • [Research] SK hynix (000660 / SKHY) – Hana | Commodity DRAM Pricing · LTA · Multiple Expansion / 2026-06-26 Research
  • [Research] LigaChem Biosciences (141080) – iM Securities | Platform Valuation · Pipeline Milestones · Deal Expansion / 2025-08-12 Research
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | High-Value Order Expansion · ASP Growth · Earnings Upward Revision / 2026-07-31 Research
  • [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Readout · ABL111 Phase 3 · Grabody B Expansion / 2026-04-07 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Supply Constraints · Multi-Year LTA · Shareholder Returns / 2026-04-24 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2024 Earnings Presentation / 2024-07-31 IR Room
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI Demand · Supply Tightness · Margin Expansion / 2026-08-11 Research
  • [Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | MLCC Price Leverage · Capacity Cannibalization · Earnings Upward Revisions / 2026-07-31 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | Profit Turnaround · ESS Margin Support · North America LFP Ramp-up / 2026-07-20 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | US ESS Demand Surges · BBU Growth · 4Q26 Turnaround / 2026-04-29 Research
  • [Research] LIG D&A (079550) – SK Securities | Modern Warfare Leader · Limited Global CapEx · Multiple Re-rating / 2026-04-07 Research
  • [Research] Celltrion (068270) – Yuanta Securities | New Product Mix Expansion · Pipeline Addition · Earnings Growth / 2026-07-28 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Cash Flow · Shareholder Returns / 2026-01-30 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme